angiography News
-
Angiodroid starts a new adventure in Poland with BERTZ MEDICAL
We are glad to announce the beginning of a new exciting adventure for the distribution in Poland for our Automated CO2 Angiography technology, together with an exclusive partner: BERTZ MEDICAL. “We are a dynamically developing company operating on the market of distribution and servicing of medical devices, and our primary value is to maintain the highest standards of offer and customer ...
-
CO2 whenever possible: the Malaysian experience
Congrats to Dr. Ismazizi B. Zaharudin and to the team of Kuala Lumpur National Heart Center – Institut Jantung Negara – for choosing CO2 as a #first contrast agent, saving the renal function of their patients. Amazing job with 40 patients treated in just a few weeks! #angiodroid #theCO2injector #ACDA #academy #CO2angiography #CO2 #procedure #zerocontrast #angiography ...
-
Medis QFR continues to show superiority over standard angiography, after a FU-period of 2 years
In the September 2022 issue of JACC journals (https://www.jacc.org/doi/10.1016/j.jacc.2022.06.044), the FAVOR III China Study Group published a sub-study that was aimed to ascertain whether the beneficial outcomes of QFR® guidance for lesion selection during PCI is affected by diabetes status. From the total of 3825 patients enrolled, 1295 (33.9%) had diabetes. The study confirmed that the ...
-
Angiodroid turns 500!
The number 500 is associated, for Italian culture, with a famous car that has marked the history of evolution and progress. We are particularly attached to this number, today more than ever. In 2021, Angiodroid exceeded 500 injectors on the market, opening up to a new age: despite the difficult times given by the Covid-19 pandemic, Angiodroid reached this milestone, which marks a new beginning ...
-
How Does FFRangio Work? - Insights from Dr. Rahul Sharma’s CVIT 2021 Presentation
FFRangio is a non-invasive, angiography-based system that provides quick, wire-free, and drug-free assessment of FFR for multiple vessels. In this video highlight from CVIT Japan 2021, Dr. Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Medical Center, gives an overview of how FFRangio works. Topics include: 3D model reconstruction – including 3D ...
By CathWorks
-
CathWorks FFRangio System Receives Regulatory Approval in Japan
CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW). The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks FFRangio System transforms routine angiogram images into objective and comprehensive physiology information, ...
By CathWorks
-
News - Angiodroid wins Gaetano Marzotto Company Prize PGMX2031
Angiodroid won the 10° edition of Gaetano Marzotto Company Prize PGMX2031 and the Special Przie Unicredit StarLab. Angiodroid wins the Company Prize as the best innovative company with the ability to generate significant positive effects in the social, territorial, cultural or environmental areas. Angiodroid doubles, also winning the special prize Unicredit Starlab, entering the ...
-
Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System
Osprey Medical (ASX: OSP) today is announcing that its DyeVert Plus Contrast Reduction System was awarded a group purchasing agreement as a Technology Breakthroughs award with Premier Inc. (Premier), a leading healthcare improvement company. Osprey Medical’s DyeVert Plus System is the only technology cleared by the U. S. Food & Drug Administration for contrast reduction and real-time ...
-
CathWorks FFRangio System Receives National Reimbursement Approval in Japan
CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System, making it more broadly available for coronary artery disease decision-making in Japan. The CathWorks FFRangio™ System has already received regulatory approval from the Japanese Pharmaceuticals and Medical Devices ...
By CathWorks
-
New interview released about Automated CO2 Angiography technology in India – PGIMER Chandigarh
Prof. M.S Sandhu from PGIMER Chandigarh #Radiology Department – India. recently gave an interview in which he illustrated the peculiarities of automatic CO2 angiography. In this interview, Prof. Sandhu remarked the Angiodroid technology. Here is a brief excerpt: “A recently developed injector with a very novel method to map these vessels is to use carbon dioxide as a ...
-
Optos plc, Unveils Silverstone, a Combined Ultra-widefield Retinal Imaging Device and UWF-Guided Swept Source OCT for the Ophthalmic Market
Optos plc, the leading medical retinal imaging company, part of Nikon Corporation, is pleased to announce the launch of Silverstone at the American Academy of Ophthalmology, San Francisco, CA. Silverstone is the first of its kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture optomap® ...
By Optos, Inc.
-
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare ...
-
Arterius Welcomes New Clinical Advisers
Arterius are pleased to welcome Prof. Patrick Serruys and Dr. Yoshi Onuma to our clinical advisory board. Prof. Serruys (Imperial College, London) will become chair of the clinical advisory board, also now featuring Dr. Onuma (Cardialysis, Netherlands) and Dr. Rasha Al-Lamee (Imperial College, London). Prof. Patrick W. Serruys is is a professor of Interventional Cardiology at the ...
-
Expand Your Diagnostic Capabilities with Vimago HDVI and Save $$$$ Through Section 179 Tax Deduction
Applications HD 3D imaging technology used in the Vimago system provides a solid volume of data, resulting in gapless, non-interpolated imaging data, delivering a 3D map of densities with spatial resolution that is the same in all three dimensions. Hard Tissue Applications: Skulls - sinus, nasal, bulla, ears, brain, oncology, trauma Orthopedics - stifles, elbows, hips, carpus/tarsus, ...
-
Saranas Recognized as One of Houston’s Most Innovative Companies
Saranas Inc., a medical device company pioneering technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been named one of Houston’s most innovative companies. Saranas is the only medical device company to be honored at the inaugural Innovation Awards presentation sponsored by the Houston Business Journal on ...
-
Mike Feher Appointed as CFO of CathWorks
CathWorks, a global leader of digital health innovation focused on helping patients with cardiovascular disease, announced today that Mike Feher was appointed Chief Financial Officer, effective immediately. An energetic and results-driven executive, Mr. Feher brings comprehensive strategic and operational finance experience to his role, including expertise in financial planning and analysis, ...
By CathWorks
-
Study Demonstrates Elucid’s Ability to Estimate RNA Expression from Non-Invasive Cardiovascular Imaging
Early detection of high risk plaque phenotypes holds the promise to prevent myocardial infarction and ischemic stroke by enabling personalized therapeutics BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, and researchers at the Karolinska Institutet (Stockholm, Sweden), led by Dr. Ulf Hedin, announced ...
By Elucid
-
Balt Receives CE Mark and Performs First-in-Man for the Silk Vista Flow Diverter
Balt (www.balt-corp.com) announced today it has received CE Mark Approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms, enabling commercialization in over 30 countries in and around the European Union. Flow diverters are intended to divert blood flow away from an aneurysm, allowing the aneurysm to heal and reducing the risk of aneurysm rupture. ...
-
Start Lab 2021: Life Science winners announced
We take a look at the first round of winning Italian start-ups that joined this year’s edition of our competion. The chosen projects were those with the highest potential and most innovative ideas in the Life sciences sector, all assessed by our jury of experts. UniCredit Start Lab, UniCredit's business platform dedicated to innovation, now at its eighth year running, was once again an ...
-
CathWorks Adds Vice President of Global Marketing to Leadership Team
CathWorks announced that Ramin Mousavi has joined CathWorks as Vice President of Global Marketing & Strategy. Mr. Mousavi, an experienced cardiovascular marketer, will take responsibility for the CathWorks FFRangio™ System U.S. clinical and commercial launch and direct future expansion into other global markets. Mr. Mousavi has over 15 years of global marketing, strategy, product ...
By CathWorks
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you